All sponsors

Gan & Lee Pharmaceuticals.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS10
PHASE 3 / 2-38
RECRUITING5
READOUTS ≤12 MONTHS3
READOUT SLIPPED >6 MO0%

Delay Index: of 6 active trials registered more than a year ago, 0 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Gan & Lee Pharmaceuticals. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
GZR4
NCT06767748
P3Active, not recruitingDiabetes6202026-02-07
GZR4
NCT06767761
P3Active, not recruitingDiabetes5802026-03-19
GZR33 Injection
NCT07527078
P3RecruitingType 2 Diabetes (T2DM)3502026-04-07
GZR102
NCT07055386
P2Active, not recruitingType 2 Diabetes Mellitus (T2DM)902026-06-28 (+2 mo)
GZR4
NCT06767735
P3Active, not recruitingDiabetes5802026-08-01 (+6 mo)
GZR4
NCT07165223
P3RecruitingDiabetes3002026-11-10
GZR101-80
NCT07387003
P2Not yet recruitingType 2 Diabetes (T2DM)3452027-02-11
GZR18
NCT07150975
P3RecruitingObesity/Overweight in Adult4202027-06-30
GZR18 injection
NCT07493057
P3RecruitingObstructive Sleep Apnea (OSA)1402027-11-14
GZR18 injection
NCT07501832
P3RecruitingObstructive Sleep Apnea (OSA)1402028-09-28